BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji T, Kohane DS. Nanoscale systems for local drug delivery. Nano Today 2019;28:100765. [PMID: 32831899 DOI: 10.1016/j.nantod.2019.100765] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang S, Cheng K, Chen K, Xu C, Ma P, Dang G, Yang Y, Lei Q, Huang H, Yu Y, Fang Y, Tang Q, Jiang N, Miao H, Liu F, Zhao X, Li N. Nanoparticle-based medicines in clinical cancer therapy. Nano Today 2022;45:101512. [DOI: 10.1016/j.nantod.2022.101512] [Reference Citation Analysis]
2 Wan S, Cong W, Shao B, Wu B, He Q, Chen Q, Shen J, Chen D, Hu H, Ye F, Fan C, Zhang H, Liu K. A library of thermotropic liquid crystals of inorganic nanoparticles and extraordinary performances based on their collective ordering. Nano Today 2021;38:101115. [DOI: 10.1016/j.nantod.2021.101115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lian Z, Ji T. Functional peptide-based drug delivery systems. J Mater Chem B 2020;8:6517-29. [PMID: 32350489 DOI: 10.1039/d0tb00713g] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
4 Xu J, Liu Y, Liu S, Ou W, White A, Stewart S, Tkaczuk KH, Ellis LM, Wan J, Lu X, He X. Metformin bicarbonate-mediated efficient RNAi for precise targeting of TP53 deficiency in colon and rectal cancers. Nano Today 2022;43:101406. [DOI: 10.1016/j.nantod.2022.101406] [Reference Citation Analysis]
5 Boonkhao B, Wang XZ, Srinophakun TR. Non-negative differential evolution for particle sizing from ultrasonic attenuation spectroscopy. Powder Technology 2021;378:602-17. [DOI: 10.1016/j.powtec.2020.10.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Li N, Cui W, Cong P, Tang J, Guan Y, Huang C, Liu Y, Yu C, Yang R, Zhang X. Biomimetic inorganic-organic hybrid nanoparticles from magnesium-substituted amorphous calcium phosphate clusters and polyacrylic acid molecules. Bioact Mater 2021;6:2303-14. [PMID: 33553817 DOI: 10.1016/j.bioactmat.2021.01.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang X, Zhang M, Wu M, Yang L, Liu R, Zhang R, Zhao T, Song C, Liu G, Zhu Q. Precise Controlled Target Molecule Release through Light-Triggered Charge Reversal Bridged Polysilsesquioxane Nanoparticles. Polymers (Basel) 2021;13:2392. [PMID: 34371994 DOI: 10.3390/polym13152392] [Reference Citation Analysis]
8 Deng B, Ma B, Ma Y, Cao P, Leng X, Huang P, Zhao Y, Ji T, Lu X, Liu L. Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment. J Nanobiotechnology 2022;20:140. [PMID: 35303868 DOI: 10.1186/s12951-022-01353-5] [Reference Citation Analysis]
9 Wu C, Wang C, Sun L, Xu K, Zhong W. PLGA nanoparticle-reinforced supramolecular peptide hydrogels for local delivery of multiple drugs with enhanced synergism. Soft Matter 2020;16:10528-36. [PMID: 33073837 DOI: 10.1039/d0sm01152e] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang P, Li Y, Tang W, Zhao J, Jing L, Mchugh KJ. Theranostic nanoparticles with disease-specific administration strategies. Nano Today 2022;42:101335. [DOI: 10.1016/j.nantod.2021.101335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
11 He R, Zang J, Zhao Y, Liu Y, Ruan S, Zheng X, Chong G, Xu D, Yang Y, Yang Y, Zhang T, Gu J, Dong H, Li Y. Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition. J Nanobiotechnology 2021;19:426. [PMID: 34922541 DOI: 10.1186/s12951-021-01169-9] [Reference Citation Analysis]
12 Zhang Y, Yue S, Haag R, Sun H, Zhong Z. An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer. J Control Release 2021;340:331-41. [PMID: 34774889 DOI: 10.1016/j.jconrel.2021.11.014] [Reference Citation Analysis]
13 Yao W, Liu C, Wang N, Zhou H, Chen H, Qiao W. Triple-responsive targeted hybrid liposomes with high MRI performance for tumor diagnosis and therapy. Mater Chem Front 2021;5:6226-43. [DOI: 10.1039/d1qm00788b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Xu J, Zhang Y, Nie G. Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges. View 2021;2:20200145. [DOI: 10.1002/viw.20200145] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shahriar SMS, An JM, Hasan MN, Surwase SS, Kim YC, Lee DY, Cho S, Lee YK. Plasmid DNA Nanoparticles for Nonviral Oral Gene Therapy. Nano Lett 2021;21:4666-75. [PMID: 34029475 DOI: 10.1021/acs.nanolett.1c00832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu Z, Ye L, Xi J, Wang J, Feng Z. Cyclodextrin polymers: Structure, synthesis, and use as drug carriers. Progress in Polymer Science 2021;118:101408. [DOI: 10.1016/j.progpolymsci.2021.101408] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
17 Zhou R, Yan L, Dong X, Zhu S, Chen K, Wu Y, Xiang H, Li L, Zhang G, Gu Z, Zhao Y. Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost. Nano Today 2021;36:101003. [DOI: 10.1016/j.nantod.2020.101003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Tian M, Xing R, Guan J, Yang B, Zhao X, Yang J, Zhan C, Zhang S. A Nanoantidote Alleviates Glioblastoma Chemotoxicity without Efficacy Compromise. Nano Lett 2021;21:5158-66. [PMID: 34097422 DOI: 10.1021/acs.nanolett.1c01201] [Reference Citation Analysis]
19 Ruan L, Chen J, Du C, Lu H, Zhang J, Cai X, Dou R, Lin W, Chai Z, Nie G, Hu Y. Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer. Bioactive Materials 2022;13:191-9. [DOI: 10.1016/j.bioactmat.2021.10.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]